couter

002424.SZGuizhou Bailing Group Pharmaceutical Co., Ltd.

Oct 27, 2026 — Q3 2026 Earnings Release (Estimated)
Chart by TradingView

The schedule

  • Tue27Oct
  • Fri15Jan
  • Tue27Apr

Resolved

  • Tue25Aug

    BULL · $4.70 at outcome

    Price reached or exceeded bull target ($4.86) at outcome date.

    Guizhou Bailing reports H1 2026 results amidst a Special Treatment (ST) listing designation and ongoing debt restructuring efforts.